acquisit dmg support wide
updat forecast estim jul
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
long pursu strategi meaning differ
peer believ critic format
wide econom moat view scale thread
connect differ busi drive competit
advantag allow compani earn excess return
time one roof unit hous largest privat health
insur lead ambulatori care health analyt franchis
soon-to-b second-largest pharmaci benefit manag
volum countri advantag network effect
gener compani size scope underpin unit wide
moat think support abil serv client lower
overal cost rival result enrol growth return
capit nearli unachiev compet firm
cvs/aetna cigna/express script merger suggest
competitor come around viewpoint think
unit lead difficult catch medium term
manag consist abl invest
industri head expect remain case
ceo david wichmann leadership whether expand firm
pbm capabl acquisit catamaran
build top health analyt product optuminsight
improv transpar medic benefit offer
pos drug rebat unit demonstr uncanni
abil remain lead edg chang affect
industri expect compani maintain leadership
posit continu product innov pursu
acquisit opportun add compet enterpris
nation dialogu around healthcar reform like intensifi
lead elect cycl contend unit
largest peer find way weather storm
rel low likelihood widespread industri disrupt
opportun privat insur continu part solut
suggest us unit like continu
earn excess return well next decad
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
largest privat health insur provid
unit state offer medic benefit nearli million member across
 intern busi leader employer-sponsor
self-direct government-back insur plan unit obtain
unriv scale compar peer manag care along
insur asset unit continu invest behind optum
franchis creat healthcar servic colossu span everyth
medic pharmaceut benefit provid outpati care
analyt affili third-parti custom
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
anoth beat-and-rais quarter
unitedhealth group post second-quart result
came modestli ahead expect back
strong growth optum steadi profit
nation largest health insur manag rais full-
year ep guidanc ahead current
estim reflect combin firm year-
to-dat strength favor outlook quarter
ahead incorpor second-quart result
recent acquir dmg asset model
rais fair valu estim current
price stock trade near time earn
estim wed recommend share wide-moat
medic membership growth came somewhat lower
forecast firm saw churn
commerci govern segment compar
first quarter howev healthi premium growth led in-
line revenu perform modestli elev
medic loss ratio off-set oper expens
came trend optum continu impress run
revenu growth acceler quarter
driven strength optumhealth optumrx
notabl pharmaci benefit manag saw strong price
acceler script growth versu year-ago level
manag indic potenti revenu shortfal
full year larg attribut move pbm
busi in-hous merg express script
close dmg provid partial off-set although firm
doesnt expect much way earn
oper year optum intend bring clinic
analyt expertis bear improv perform
medic practic wouldnt surpris
see dmg eventu contribut mid- high-single-digit
margin normal basi
rais fair valu estim per share
impli roughli time updat
estim adjust earn ebitda
respect increas larg attribut
strong perform year date inclus
recent acquir dmg asset project
cash flow receiv sinc last updat
valuat underpin assumpt unit
continu expand medic insur enrol
roughli annual come five year
govern commerci intern busi
contribut growth time remain
hallmark firm uniqu competit advantag
estim premium growth line mid-single-digit cost
trend assumpt limit improv overal
medic loss ratio oper ratio leav insur
compani oper margin roughli flat time
assum optum perform remain somewhat
dynam forecast optuminsight optumhealth
increas revenu low-double-digit rate compar
high singl digit rest firm separ
presum area also like benefit
futur acquisit activ optum remain growth
powerhous compani busi alreadi
oper manag target margin rang
leav upsid somewhat cap view assum
modest margin expans segment
mix
assumpt result consolid revenu growth
annual next five year overal
ebitda margin hold steadi roughli
forecast period growth rate combin healthi
alloc share repurchas drive ep growth toward
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
bear-cas assumpt result stark deceler
compani perform versu last hand year
instanc forecast medic enrol growth
oper margin contract basi point
per year compani insur book optum also slow
meaning overal segment grow
rate annual next five year optumrx real
laggard scenario driven weaker script volum
price declin annual overal result
revenu growth enterpris roughli
ebitda margin declin
termin year forecast result fair valu estim
per share time lower estim
adjust earn ebitda respect
annual rate
given consist cash flow gener
leadership posit manag care give unit
bull-cas scenario assum firm abl
increas insur membership annual
next five year mid-single-digit cost trend
assumpt companywid instanc give firm
credit overcom mix headwind stem
outsiz growth enrolle government-sponsor
plan assum expand insur margin
basi point faster year base-cas forecast
culmin overal revenu growth nearli
ebitda margin reach
termin year bull-cas view result fair valu
estim per share time higher
estim adjust earn ebitda
view uniqu posit
healthcar sector broadli compar peer
managed-car industri unit breadth scope put
leagu opinion form
underpin wide moat rate unit
busi franchis would probabl moatworthi
integr medic benefit
pharmaceut manag ambulatori care
network strengthen perform durabl
entir enterpris convinc unit scale
cohes servic model make like
compani continu earn excess return
sharehold come two decad
sheer size unit insur book creat
foundat wide moat rate million
approxim insur popul term
premium written lead
like view provid space believ
managed-car offer better analyz local
market len given state-level regulatori requir
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
need convinc local group provid particip
plan network nation level insur
industri look rel competit drill
state-level market dynam clear much
industri well consolid believ lead
incumb industri reap benefit
entrench market posit regard unit
second none
within framework believ health insur benefit
two primari moat sourc cost advantag
network effect advantag thought two
way relat size insur book
busi first larger membership base allow greater
increas profit
potenti margin member overal enterpris
second larger membership base allow greater
negoti leverag versu provid insur
need creat plan network allow lower medic
cost per member opportun lower premium
improv benefit offer secur enrol growth
rare instanc healthcar system focus build
local scale shift balanc power
relationship given much higher
level
concentr found managed-car industri larg
think scale frequent tip insur favor
network effect also play intertwin role
patient payer provid incumb plan
enrol grow relationship among three
entiti becom valuabl time patient
becom rel afford plan invest
broader swath benefit member payer
expand enrol allow greater per-memb
profit attract offer either
better price entic benefit packag
provid particip expand plan network
provid access greater patient volum key compon
profit busi high fix cost
short run dynam creat barrier entri
would-b competitor put togeth attract
price provid network new geographi prohibit
difficult without membership pool vice versa
unit scale allow cost network advantag
take root support best-in-class return capit
look largest peer unit insur oper
boast lowest per-memb rate medic claim paid
suggest membership base given sizabl
leverag healthcar provid
contract relationship optumhealth also probabl
play uniqu role lower cost translat
commerci premium monthli rate trend
narrow-moat peer two key way first scale
scope unmatch state-by-st basi unit
posit either largest second-largest insur
term premium written state come
second metric number-on -two posit
state translat best-in-class
cost-per-memb profil busi allow unit
price product ensur disproportion enrol
growth time second import
insur compani relationship unit optum
franchis creat uniqu cost advantag believ
difficult competitor replic
two optum segment believ contribut
unit wide moat optumrx pharmaci benefit
manag optumhealth ambulatori care busi
affili unit insur oper one
largest pbm outpati servic provid countri
make sizabl cost benefit compar less
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
integr peer contend firm ownership
optumrx allow unit target lower margin
insur book secur enrol make
lost profit cross-sel newli insur group
pharmaci benefit program view strategi
key unit success drive industry-lead
perspect unit affili optumhealth
asset allow better manag care member
encourag use lower-cost-of-car site oper
state manag claim servic medicar
advantag member nearli cheapli
tradit medicar market insur
busi optumhealth asset overlap
moat
optumhealth possess characterist
typic attribut moatworthi busi
stand-alon basi think incred valuabl asset
hand fulli integr healthcar servic
provid optumrx hand probabl built
advantag franchis industri much
manag develop attract oligopoli
top three pbm account roughli
claim process nationwid busi like
managed-car organ benefit cost advantag
afford scale abl amass
consolid three industri leader adjud
billion adjust script annual allow
sizabl oper leverag improv econom
margin script pbm abil consolid
buy power help drive valu client discount
dispens pharmaci drug
manufactur final relationship
extrem sticki time retent rate
three nation pbm averag high year
unit integr strategi view right
one healthcar system slowli shift
fee-for-servic model one align valu
outcom produc patient recent horizont
consolid among cvs/aetna cigna/express script
valid view lead industri particip
scrambl best mimic unit core busi model
believ busi formid
competitor come year anticip
combin erod unit underli competit
posit meaning degre
think underli sourc underpin econom
moat manag care larg stabl assign
group stabl moat trend rate
last five year character nearli
unpreced chang health insur market
unit consist report industry-lead return
invest capit look forward view scenario
firm underli cost advantag network
effect materi erod substanti strengthen
growth like come lower-margin medicar
cohort forese futur view
result mix effect sever enough suggest
firm underli competit advantag weaken --
fact return invest capit econom
profit project modestli expand
forecast period driven growth higher-margin optum
similarli enrol industri level may face
cyclic challeng associ weaken economi
rise uninsur rate unit well equip mitig
shift industry-lead medicaid franchis
may pressur return short run firm
abil post midteen return throughout give
us ad confid moat trend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ounit strategi pursu scale across multipl
synergi among insur provid pbm
segment result meaning edg pure-
oth firm nation breadth give advantag
build local-market provid network act
barrier entri plan new specif state
oth bulk insur membership growth
come year stem cohort lower-margin
headwind insur profit
ohealthcar reform like recur topic
throughout upcom elect cycl
could creat increas stock volatil pose real
fundament threat public-opt propos
allow price insur offer
attract drive above-p enrol growth
washington look reduc nation drug price
transpar pbm industri could creat ad
risk profit unit optumrx segment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
unit remain excel financi shape gross debt
balanc hover around time adjust ebitda
somewhat conserv leverag profil compani
level consist free cash flow gener
roughli slightli manag long-term
target near provid ampl opportun
manag opportunist util strength
balanc sheet return excess cash flow
interim believ firm
optumhealth optuminsight busi like
see bolt-on addit wouldnt surpris see
manag acquir addit insur asset
intern segment manag focus
dividend increas share buyback return capit
sharehold expect continu
risk regulatori chang ever present
healthcar payer provid think breadth
unit oper
leader across government-
benefit adjud ambulatori care health
analyt firm revenu cash flow stream much
less reliant singl sourc mani area
industri furthermor unit insur oper
span geographi leav exposur particular
state less import peer final
rhetor around healthcar reform probabl intensifi
elect season think passag
implement sweep chang remain remot
possibl think chang margin like
modif afford act continu
expans medicaid creat earli buy-in option
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
medicar wouldnt surpris see privat
insur play role improv coverag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
american fund growth fund amer
capit research manag compani
new york mellon corp
share
fund
share
fund
record success think unit current
execut team rank among top echelon leader
healthcar servic manag shown impress
strateg foresight build unit busi
today stay year ahead competit
maintain industry-lead return capit think
qualiti merit exemplari stewardship
rate believ manag uniqu posit
continu success shepherd compani
ever-chang healthcar system unit state
current ceo david wichmann step top spot
transit execut chairman role like hemsley
wichmann nearli year experi unit
spent time leadership role across enterpris
experi optum unitedhealthcar
cfo presid combin
wichmann well equip continu firm legaci
success opinion
along highli capabl leader throughout differ
busi think firm put place solid
incent structur ensur align manag
sharehold bulk wichmann compens
variabl tie performance-bas measur via
perform share restrict stock option annual
goal consist revenu oper incom cash flow
target along continu improv firm net
promot score measur long-term compens tie
cumul three-year ep measur return equiti
target help balanc growth profit
oper effici like see final
encourag level insid ownership
necessarili stand percentag basi
wichmann hemsley hundr million tie
compani stock
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
huge determin stewardship rate
pleas compani long-standing polici
separ role ceo board chairman
addit hemsley appoint
took role lead independ director
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
anoth beat-and-rais quarter
unitedhealth group post second-quart result
came modestli ahead expect back
strong growth optum steadi profit
nation largest health insur manag rais full-
year ep guidanc ahead current
estim reflect combin firm year-
to-dat strength favor outlook quarter
ahead incorpor second-quart result
recent acquir dmg asset model
rais fair valu estim current
price stock trade near time earn
estim wed recommend share wide-moat
medic membership growth came somewhat lower
forecast firm saw churn
commerci govern segment compar
first quarter howev healthi premium growth led in-
line revenu perform modestli elev
medic loss ratio off-set oper expens
came trend optum continu impress run
revenu growth acceler quarter
driven strength optumhealth optumrx
notabl pharmaci benefit manag saw strong price
acceler script growth versu year-ago level
manag indic potenti revenu shortfal
full year larg attribut move pbm
busi in-hous merg express script
close dmg provid partial off-set although firm
doesnt expect much way earn
oper year optum intend bring clinic
analyt expertis bear improv perform
medic practic wouldnt surpris
see dmg eventu contribut mid- high-single-digit
margin normal basi
first report juli axio trump administr
plan final propos rule alter flow
drug rebat purchas medicar part plan
rule would chang busi model
pharmaci benefit manag requir negoti
discount pass directli beneficiari
point sale rather use mechan lower
cost insur plan overal led ralli
pbms/insur distributor drug stock sank
investor wonder presid donald trump focu
turn next take rebat reform tabl put
pressur congress particularli bipartisan senat
financ committe team chuck grassley ron wyden
reveal drug-pric packag month stand
chanc pass chamber potenti reform
like reduc cost medicar patient also look
modest payer drug firm
think remain propos review
budget offic -- medicar part intern price
index -- unlik implement even final
congress power block rule judici review
could find massiv demonstr overextens
author center medicar medicaid
innov cmmi
altern expect senat drug price packag
could includ part reform also includ cap
out-of-pocket spend medicar part anticip
propos would see widespread support
policymak result higher likelihood
success think chang would manag
drug firm effect achiev bipartisan
polici goal lower healthcar cost american
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
addit detail analysi effect
rebat rule elimin pleas see report rebat
unit under-valued jun
market close june feder trade
commiss releas detail complaint
agreed-to settlement
group satisfi anti-trust concern stem unit
purchas davita medic group announc
bring roughli year-and-a-half transact process
close receiv report sale price
billion asset anticip cash infus
go toward debt reduct share repurchas
near termact applaud given steep discount
versu per share fair valu estim intend
alter valuat narrow- wide-moat rate
either unit respect result deal
ftc object base concentr market
power nevada unit particularli strong
insur presenc specif unit purchas
dmg la vegas-area medic practic would put
optumcar posit cover roughli medicar
advantag member region creat incent
anticompetit action contract area
parti agre divest practic
intermountain healthcar within next day
remedi alleg effect
conclus process mark first bit posit
news best idea davita time
transact final manag given flexibl
shore firm balanc sheet path toward
oper improv derisk capit
structur perspect continu see sizabl upsid
share current level believ share repres one
compel opportun healthcar
sector long-term investor
fair valu estim apr
post first-quart result gener
met expect stand firm fair
valu estim overal quest saw mix bag factor
incorpor estim full year
expect pama-l reimburs pressur
continu exert expect
let next three-year cycl set
medicar clinic lab fee schedul begin roll
hand quest organ volum growth
first quarter respect perspect
believ volum continu grow
longer term continu think quest rival labcorp
largest lowest-cost produc best
posit weather medicar cut gain scale
industri consolid progress ultim trend
solidifi quest narrow econom moat
wide expect chose quest
non-exclus prefer network lab provid
time end contract higher-cost lab
quest also confirm suspicion firm avoid
signific price concess weve seen past
switch quest labcorp
decad ago see evid
payer less interest squeez price
lowest-cost produc play
interest increas access quest
labcorp offer nation scope expens
aim tap ream diagnost data quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
labcorp amass part larger effort better
manag patient outcom value-bas reimburs
take hold think trove diagnost data
extrem compel unitedhealth optum unit
alreadi analyz treatment outcom data manag
cost heighten qualiti
thu surpris payer follow
path pave includ aetna horizon
cross shield new jersey cross
shield georgia anticip trend toward non-
exclus contract benefit quest labcorp
offer widespread access lower cost
also intrigu trident file chapter
view canari coal mine come
pama cut trident major diagnost lab
signific presenc nurs home long-term care
sub-seg market independ lab serv
custom typic receiv total revenu
medicar stark contrast quest
receiv less revenu directli
medicar wouldnt surpris see
independ lab substanti medicar exposur
close next two year quest labcorp
unlik pursu new sourc volum
subsequ loss access underscor second
thought trade-off zeal institut
pama-l cut
first-quart perform unitedhealth group track
slightli better expect howev
intend make mani chang project
anticip fair valu estim remain larg
unchang impli roughli time estim
adjust earn market current valu
stock time think investor would well
serv pick share wide-moat enterpris
consolid revenu growth continu impress
versu prior-year period optum segment
medic benefit busi contribut profit
improv overal oper margin expans
approxim basi point bulk improv
stem medic loss ratio came basi
point better anticip lower oper cost
larg attribut suspens health insur
fee fiscal membership growth fell less
line expect albeit weaker perform
at-risk cohort off-set smaller acquisit
commerci self-insur segment ad approxim
live unit book manag rais
earn per share forecast line
project
manag suggest employ health
plan provid posit feedback decis
past month take lead move fulli
insur self-insur membership plan design
provid pos rebat brand drug prescript
compani expect offer
meaning impact margin structur pharmaci
benefit manag alreadi pass roughli
negoti rebat ultim plan sponsor
whether govern anoth health plan
pend final propos rebat rule
expect come week potenti impact
product price profit top
mind investor manag indic intend
particip demonstr program outlin
center medicar medicaid servic earlier
month govern accept bid propos
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
current regulatori regim offer risk corridor
partial subsid cost overrun result see
polici chang implement plan year
program run two year cover cost
deviat target beyond first basi point
think help reduc potenti variabl plan
bid insur prepar submit propos earli
separ manag address on-going public
debat around variou medicar propos put
forward washington recent month commentari
consist expect countri largest
privat insur headlin address topic seem
weigh heavili stock throughout healthcar
sector past sever week managed-car
compani particularli affect believ
passag sweep regul like
suggest investor take advantag shorter-term valuat
disloc driven shift sentiment
underli fundament fit descript
well share approach multi-year valuat low
measur price-to-earnings
fair valu chang across board
taken fresh look managed-car industri
come away bit construct health insur
broadli rais moat rate unitedhealth
wide narrow narrow none
respect addit revisit industrywid
neg moat trend outlook bump unit stabl
weve assign posit trend rate
larg attribut competit benefit expect
busi achiev integr aetna
express script respect
unit rais fair valu estim per
share larg driven moat upgrad
optimist long-term assumpt franchis
think unit uniqu deserv wide moat rate
driven cost advantag network effect
embed within largest privat health insur
organ nationwid unriv scale allow firm
price insur book commensur lowest cost
per insur member firm cover led
industry-lead gain membership past five
think merger creat
organ deserv narrow moat rate result
rais fair valu estim per share
think combin medic
strateg
sound underpin posit trend rate integr
execut
out-performance
final trim fair valu estim
per share account recent result
manag outlook came
expect larg attribut weak no-
moat retail long-term care segment think aetna
transact ultim lead improv competit
posit appear trend ahead initi
point investor toward unit highest-
convict idea trade compel discount
revis estim intrins valu unit
current trade near time estim
adjust earn investor opportun buy
above-averag busi below-averag valuat
firm diversifi oper make less prone
regulatori disrupt peer view lead
posit insur ambulatori care data analyt
pharmaci benefit give advantag competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
find hard replic best-in-class busi
combin exemplari stewardship give us confid
long-run trajectori firm think
stapl investor healthcar portfolio
outlook bit muddi firm
pharmaci busi cater long-term care market
continu period prolong weak
view core firm thesi would
encourag investor look volatil toward
long-term earn power combin
aetna think transact put firm nearest
unit term competit posit although
relianc pharmaci pbm oper make somewhat
prone regulatori disrupt stock trade
time estim adjust earn
market appear take pessimist view
opinion -- despit reduct fair valu stock
remain territori
like strateg decis bring
togeth think firm expos
idiosyncrat risk three busi
account roughli firm-wide oper profit
estim leav expos policy-driven chang
percol within pbm industri addit
transact complet cusp lose
largest custom manag took
account evalu valuat busi
like open door increment unknown
run-of-the-mil megamerg given rel higher
estim uncertainti think
unit offer attract risk-adjust return
hh propos chang drug rebat system pbm
outlook risk feb
depart human servic propos
rule jan aim untangl opaqu price
incent scheme exist current rebat
system prescript drug rule attempt forc
pass-through drug manufactur discount plan
beneficiari point sale expressli exclud
safe-harbor provis antikickback statut
discount paid medicar part medicaid
managed-car organ net effect pharmaci
benefit manag econom theoret
minim face valu rebat government-
sponsor plan alreadi pass one
way anoth think bigger risk potenti
spillov privat market
today bulk rebat throughout system use
buy plan premium lower monthli payment
expens higher co-insur requir
member cost-shar arrang typic struck
manufactur gross net price
altern propos hh forc plan appli
rebat counter lower out-of-pocket requir
beneficiari trade-off higher monthli premium
expect pbm industri loudest critic
polici transit rebateless system would difficult
uncertain mani unintend consequ
associ replac nationwid price system
industri
stakehold come month perceiv
pitfal could affect variou link suppli chain
like becom clear intend
chang project fair valu estim
compani cover result propos
watch progress close better determin
govern math line mani
compani space say follow
request inform topic center
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oper affect addit hh explicitli
refer long-standing polici disallow price
reduct offer payer avail
medicar medicaid may hamstr
effect pbm formulari tier potenti
polici open door chang commerci
market seem rel straightforward result hh
intend defer congress regulatori author
relat privat insur wait see
pbm intend step around languag await
inquiri congression committe path
toward wide-rang chang seem rel clear
propos implement written
second along chang type discount
allow industri rule intend exclud
nonreb pbm servic fee tie list price volum
metric safe-harbor provis hh would
expressli permit flat-fe arrang attempt
better align incent among plan sponsor pbm
drug manufactur potenti magnitud chang
unclear think neg pbm profit
medicar medicaid servic late
proactiv provid pos arrang
fulli insur member seen littl interest
pos part offer given sticker shock
higher premium express script suggest
lower price beneficiari would off-set
higher premium
payment -- conclus govern ultim seem
agre depart initi goal implement
chang effect jan think timelin
probabl optimist
polici chang like would benefit minor
sickest highest-cost patient accord hh
beneficiari enrol part would see net
reduct total drug cost nearli
popul would probabl see premium
increas greater save gener
pharmaci counter aggreg cost beneficiari
program whole would declin period
remain receiv coverag low-
incom subsidi program probabl wouldnt see much
individu would see overal benefit aggreg
spend could actual increas next decad due
higher outlay feder govern accord
propos increas direct subsidi payment
surpass save lower reinsur spend
beneficiari catastroph phase coverag lower
cost-shar requir low-incom
subsidi conclus back scenario analys
compil hh
pbm face risk propos two key
reason view first adjust accept
safe harbor creat inher legal risk
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
